Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08AAB
|
|||
| Drug Name |
VLX600
|
|||
| Synonyms |
GCXMWESEENEVIC-UHFFFAOYSA-N
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Vivolux Uppsala, Sweden
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H15N7
|
|||
| Canonical SMILES |
CC1=C2C(=CC=C1)C3=C(N2)N=C(N=N3)NN=C(C)C4=CC=CC=N4
|
|||
| InChI |
1S/C17H15N7/c1-10-6-5-7-12-14(10)19-16-15(12)22-24-17(20-16)23-21-11(2)13-8-3-4-9-18-13/h3-9H,1-2H3,(H2,19,20,23,24)/b21-11+
|
|||
| InChIKey |
UQOSBPRTQFFUOA-SRZZPIQSSA-N
|
|||
| CAS Number |
CAS 327031-55-0
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.